Incyte Pathology, P.S
Spokane Valley, WA Doing business as Incyte Diagnostics
- UEI
- HEBDADSTJDH5
- CAGE
- 1NJ68
- SAM.gov registration
- Active through
Company facts
- FY2025 rankings
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- Other NAICS codes in SAM.gov
- SAM.gov registration date
- Physical address
- 13103 E Mansfield Ave, Spokane Valley, WA 99216, USA
- Website
- incytepathology.com
- Founded
- 1957
- Employees
- 251-1K
- Estimated annual revenue
- $10M-$50M
- Industry
-
- Health Care
- Health Care Equipment & Services
- Health Care Providers & Services
- Health Care Services
- SIC code
- 80 Health Services
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract obligations by fiscal year
| Fiscal year | Obligated |
|---|---|
| FY2027 To date | $0 |
| FY2026 | $629,065 |
| FY2025 | $585,330 |
| FY2024 | $360,329 |
| FY2023 | $958,717 |
Top agencies by obligations
| Rank | Agency | Obligated, FY2026–FY2027 | Share |
|---|---|---|---|
| 1 | Department of Veterans Affairs | $629,065 |
Contract awards
Latest 5 listed here. See the rest on GovTribe.
Similar vendors
| Vendor | Location | Primary NAICS |
|---|---|---|
| The Association Of University Physicians | Seattle, WA | 541219 Other Accounting Services |
| Arup Laboratories Inc. | Salt Lake City, UT | 621511 Medical Laboratories |
| Renown Health | Reno, NV | 622110 General Medical and Surgical Hospitals |
| Utah Pathology Services, Inc. | Salt Lake City, UT | 621511 Medical Laboratories |
| Stjoseph's Via Christy Medical Center | — | 621111 Offices of Physicians (except Mental Health Specialists) |
About the company
Incyte Pathology, P.S., doing business as Incyte Diagnostics, is a for-profit clinical diagnostic laboratory based in Spokane Valley, Washington that provides pathology reference laboratory testing, cytology services, and anatomic diagnostic services exclusively to the federal government as a prime contractor. The vendor competes in the full-and-open market with no set-aside designations across its federal footprint and has maintained a consistent contracting relationship with the Department of Veterans Affairs since at least 2001.
The vendor's customer base is heavily concentrated within VA networks. The Department of Veterans Affairs accounts for 30 awards across the portfolio, with Veterans Integrated Service Network 20 (VISN 20)—the Pacific Northwest regional network—anchoring $11.1 million in combined potential value across 14 awards, representing 91% of the vendor's total federal revenue. The Department of the Air Force Air Mobility Command contributes a marginal $156 thousand across five awards. This concentration reflects Incyte Diagnostics' positioning as a regional clinical laboratory serving VA medical facilities in Washington and the broader Pacific Northwest.
The vendor's federal work is organized under a single-award Blanket Purchase Agreement with VISN 20 (36C26022A0001), established May 1, 2022, with a $2.9 million ceiling running through April 30, 2027. Annual BPA calls issued on May 1 represent the core vehicle: initial call in FY2022 valued at $684,802; FY2023 call at $601,993; FY2024 call at $585,330; FY2025 increase-of-funds call at $670,251; and the most recent FY2026 call at $499,918. Task order values have declined year over year, reflecting established partnership and streamlined procurement of recurring diagnostic services. A separate purchase order with VISN 20 for Walla Walla VA Medical Center pathology reference lab testing was awarded July 1, 2022, for $83,788.
Activity has been minimal in recent years—one award per year from 2023 through 2026—following three awards in 2022, but the vendor carries forward a consistent, low-volume federal diagnostic-services practice. Combined potential value across all awards in the portfolio is $12.2 million, with $10.9 million obligated. One award carrying $500 thousand in potential value reaches ultimate completion within the next twenty-four months, creating modest recompete exposure. The vendor operates as a direct service provider with no subcontractor engagement across SCI-reportable prime records; SCI invoicing from FY2023 and FY2024 totaled $2.4 million. The vendor's lack of prime contract IDV seats or GWAC vehicles, combined with its narrow geographic and customer focus, positions it as a specialized regional provider rather than a scaled federal contractor.
Quick answers
Is Incyte Pathology, P.S registered in SAM.gov?
Yes. Incyte Pathology, P.S's SAM.gov registration is active through December 11, 2026.
How much has Incyte Pathology, P.S received in federal contracts?
Federal contracts obligated $585,330 to Incyte Pathology, P.S in fiscal year 2025 and $2,533,442 in fiscal years 2023 through 2027.
How does Incyte Pathology, P.S rank among federal contractors?
Incyte Pathology, P.S ranked #65 in NAICS 621511, #86 in NAICS 6215 and #88 in PSC Q3 in FY2025.
What is Incyte Pathology, P.S's most recent federal award?
Incyte Pathology, P.S's most recent federal contract award is Pathology lab services (36C26026N0134), from Veterans Integrated Service Network 20 (VHA), on May 1, 2026.
On GovTribe
See Incyte Pathology, P.S's full federal record
- Federal contract awards
- IDV awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors